We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Jan 2021 - 27 Jan 2021
Virtual Venue
24 Feb 2021 - 28 Feb 2021
Virtual Venue

Factors Associated with ARDS in COVID-19 Identified

By LabMedica International staff writers
Posted on 30 Mar 2020
Print article
Image: Factors associated with acute respiratory distress syndrome (ARDS) In COVID-19 identified (Photo courtesy of the Brian Orelli, PhD).
Image: Factors associated with acute respiratory distress syndrome (ARDS) In COVID-19 identified (Photo courtesy of the Brian Orelli, PhD).
Patients with COVID-19 present primarily with fever, myalgia or fatigue, and dry cough. Although most patients are thought to have a favorable prognosis, older patients and those with chronic underlying conditions may have worse outcomes.

Patients with severe illness may develop dyspnea and hypoxemia within one week after onset of the disease, which may quickly progress to acute respiratory distress syndrome (ARDS) or end-organ failure. The clinical characteristics and factors associated with developing ARDS after hospital admission and progression from ARDS to death in patients with COVID-19 pneumonia.

A team of medical scientists collaborating with Zhongshan Hospital (Shanghai, China) carried out a retrospective cohort study of 201 patients aged 21 to 83 years with confirmed COVID-19 pneumonia hospitalized at Jinyintan Hospital in Wuhan, China. To identify SARS-CoV-2 infection, throat swab samples were obtained from all patients at admission and tested using real-time reverse transcriptase–polymerase chain reaction assays. Additionally, patients underwent blood routine blood test, coagulation, and biochemical tests and chest x-rays or computed tomography.

The most commonly self-reported symptoms at onset included fever (93.5%), cough (81.1%), productive cough (41.3%), dyspnea (39.8%) and fatigue or myalgia (32.3%). Approximately three-quarters presented with fever and cough, more than one-third presented with fever and dyspnea, approximately one-third presented with fever and fatigue, myalgia or headache and only 6.5% presented with fever alone. At last follow-up, 71.6% of patients were discharged from the hospital. Of the 41.8% patients who developed ARDS during the study, slightly more than half died.

The team reported that of 194 patients, 166 (85.6%) demonstrated increased high-sensitivity C-reactive protein. More than half (126/197 [64.0%]) of this cohort had lymphocytopenia. About one-third (68/197 [34.5%]) of patients had neutrophilia. Approximately one-quarter (46/197 [23.4%]) of patients had leukocytosis. Some patients demonstrated liver injury with elevated aspartate aminotransferase (AST; 59/198 [29.8%]) and alanine aminotransferase (ALT; 43/198 [21.7%]). Most patients presented with an elevated myocardial indices: 194/198 (98.0%) had elevated lactate dehydrogenase (LDH) and 9/198 (4.5%) had an elevated creatine kinase muscle-brain isoform. Few patients had kidney injury indicated by elevated plasma urea (9/198 [4.5%]) and serum creatinine (9/198 [4.5%]). Of 195 patients, four (2.1%) presented with prolonged prothrombin times (PTs). The team noted that interleukin-6 (IL-6) was statistically significantly associated with death.

The authors wrote that their findings suggest that for patients with COVID-19 pneumonia, methylprednisolone treatment may be beneficial for those who have developed ARDS on disease progression. The study was published on March 13, 2020 in the journal JAMA Internal Medicine.

Related Links:
Zhongshan Hospital

Print article


Molecular Diagnostics

view channel
Image: Schematic representation of Chiari malformation type 1; it involves the lower part of the cerebellum known as tonsils, but not the brain stem (Photo courtesy of Healthline).

Common Brain Malformation Traced to Its Genetic Roots

About one in 100 children has a common brain disorder called Chiari 1 malformation, but most of the time such children grow up normally and no one suspects a problem. However about one in 10 of those children,... Read more


view channel
Image: uPath HER2 Dual ISH image analysis for breast cancer (Photo courtesy of Roche)

Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer

Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.